- Home
- OXM vs ALLO Comparison
OXM vs ALLO Comparison
Compare OXM & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OXM | ALLO |
|---|---|---|
| Founded | 1942 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 597.7M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OXM | ALLO |
|---|---|---|
| Price | $26.34 | $1.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $38.00 | $8.35 |
| AVG Volume (30 Days) | 481.0K | ★ 4.8M |
| Earning Date | 06-10-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | ★ 34.09 |
| EPS | ★ 4.25 | N/A |
| Revenue | ★ $1,477,834,000.00 | N/A |
| Revenue This Year | $2.85 | N/A |
| Revenue Next Year | $2.63 | $142,416.42 |
| P/E Ratio | $6.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.85 | $1.04 |
| 52 Week High | $49.58 | $4.46 |
Technical Indicators
Market Signals| Indicator | OXM | ALLO |
|---|---|---|
| Relative Strength Index (RSI) | 24.33 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $42.57 | N/A |
| Average True Range (ATR) | 1.41 | 0.00 |
| MACD | -0.39 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).